首页> 外文OA文献 >Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli.
【2h】

Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli.

机译:通过在大肠杆菌中表达的因子VIII片段的缺失分析,对人VIII因子抑制剂抗体的表位作图。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Epitopes for antibodies that inhibit factor VIII procoagulant protein were analyzed by deletion mapping of factor VIII protein fragments expressed in Escherichia coli. A human factor VIII cDNA clone was used to generate E. coli expression vectors encoding fragments containing the 80-kDa factor VIII light chain (A3, C1, and C2 domains) and the 44-kDa carboxyl-terminal half of the factor VIII heavy chain (A2 domain). A series of deletions of each fragment was constructed and tested by immunoblotting for the binding of alloantibody and autoantibody inhibitors. Analysis of derivatives of the 80-kDa fragment showed that six inhibitors recognized a major epitope(s) within the carboxyl-terminal 17.3 kDa of factor VIII. These inhibitors also recognized weaker epitopes nearby and one inhibitor recognized epitopes scattered throughout the 80-kDa fragment. Deletions within the heavy chain fragment revealed one epitope-containing region confined to the amino-terminal 18.3 kDa recognized by six inhibitors. Bacterially produced factor VIII fragments containing the major epitopes were capable of neutralizing inhibitors in vitro but fragments containing weaker or no epitopes did not. These data suggest a potential therapeutic use of factor VIII fragments for neutralization of inhibitor antibodies.
机译:通过在大肠杆菌中表达的因子VIII蛋白片段的缺失作图来分析抑制因子VIII促凝血蛋白的抗体的表位。人类VIII因子cDNA克隆用于产生大肠杆菌表达载体,该载体编码的片段包含80-kDa VIII因子轻链(A3,C1和C2结构域)和VIII因子重链的44-kDa羧基末端一半(A2域)。构建了每个片段的一系列缺失,并通过免疫印迹测试了同种抗体和自身抗体抑制剂的结合。对80-kDa片段的衍生物的分析表明,六种抑制剂识别了因子VIII的羧基末端17.3kDa内的主要表位。这些抑制剂还识别附近较弱的表位,一种抑制剂识别遍及整个80 kDa片段的表位。重链片段内的缺失揭示了一个包含表位的区域,该区域被六种抑制剂识别为氨基末端的18.3 kDa。细菌产生的包含主要表位的因子VIII片段能够在体外中和抑制剂,但包含较弱或没有表位的片段则不能。这些数据表明因子VIII片段用于中和抑制剂抗体的潜在治疗用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号